Global Percutaneous Left Atrial Appendage Closure Device 麻豆原创 Growth 2025-2031

Publication ID:

LPI03258718

Publication Date:

March 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Percutaneous Left Atrial Appendage Closure Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Percutaneous Left Atrial Appendage Closure Device players cover Abbott Laboratories, AtriCure, Boston Scientific Corporation, Johnson and Johnson, Lifetech Scientific Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧ercutaneous Left Atrial Appendage Closure Device Industry Forecast鈥� looks at past sales and reviews total world Percutaneous Left Atrial Appendage Closure Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Percutaneous Left Atrial Appendage Closure Device sales for 2025 through 2031. With Percutaneous Left Atrial Appendage Closure Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Left Atrial Appendage Closure Device industry.
This Insight Report provides a comprehensive analysis of the global Percutaneous Left Atrial Appendage Closure Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Left Atrial Appendage Closure Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Percutaneous Left Atrial Appendage Closure Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Left Atrial Appendage Closure Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Left Atrial Appendage Closure Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Left Atrial Appendage Closure Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Endocardial LAA Closure Devices
Epicardial LAA Closure Devices
Segmentation by Application:
Hospitals
Ambulatory Surgery Centres
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
AtriCure
Boston Scientific Corporation
Johnson and Johnson
Lifetech Scientific Corporation
Occlutech GmbH
Biosense Webster Inc
SentreHeart Inc.
MEDX Xelerator LP
Cardia Inc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Percutaneous Left Atrial Appendage Closure Device market?
What factors are driving Percutaneous Left Atrial Appendage Closure Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Percutaneous Left Atrial Appendage Closure Device market opportunities vary by end market size?
How does Percutaneous Left Atrial Appendage Closure Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Country/Region, 2020, 2024 & 2031
2.2 Percutaneous Left Atrial Appendage Closure Device Segment by Type
2.2.1 Endocardial LAA Closure Devices
2.2.2 Epicardial LAA Closure Devices
2.3 Percutaneous Left Atrial Appendage Closure Device Sales by Type
2.3.1 Global Percutaneous Left Atrial Appendage Closure Device Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Type (2020-2025)
2.4 Percutaneous Left Atrial Appendage Closure Device Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgery Centres
2.4.3 Others
2.5 Percutaneous Left Atrial Appendage Closure Device Sales by Application
2.5.1 Global Percutaneous Left Atrial Appendage Closure Device Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Percutaneous Left Atrial Appendage Closure Device Breakdown Data by Company
3.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Company (2020-2025)
3.1.2 Global Percutaneous Left Atrial Appendage Closure Device Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Company (2020-2025)
3.2.1 Global Percutaneous Left Atrial Appendage Closure Device Revenue by Company (2020-2025)
3.2.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Company
3.4 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Product Location Distribution
3.4.2 Players Percutaneous Left Atrial Appendage Closure Device Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Percutaneous Left Atrial Appendage Closure Device by Geographic Region
4.1 World Historic Percutaneous Left Atrial Appendage Closure Device 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Percutaneous Left Atrial Appendage Closure Device 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.4 APAC Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.5 Europe Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.6 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Growth
5 Americas
5.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country
5.1.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
5.1.2 Americas Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
5.2 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
5.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region
6.1.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region (2020-2025)
6.1.2 APAC Percutaneous Left Atrial Appendage Closure Device Revenue by Region (2020-2025)
6.2 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
6.3 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Percutaneous Left Atrial Appendage Closure Device by Country
7.1.1 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
7.1.2 Europe Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
7.2 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
7.3 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device by Country
8.1.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
8.3 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Left Atrial Appendage Closure Device
10.3 Manufacturing Process Analysis of Percutaneous Left Atrial Appendage Closure Device
10.4 Industry Chain Structure of Percutaneous Left Atrial Appendage Closure Device
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Percutaneous Left Atrial Appendage Closure Device Distributors
11.3 Percutaneous Left Atrial Appendage Closure Device Customer
12 World Forecast Review for Percutaneous Left Atrial Appendage Closure Device by Geographic Region
12.1 Global Percutaneous Left Atrial Appendage Closure Device 麻豆原创 Size Forecast by Region
12.1.1 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Region (2026-2031)
12.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Type (2026-2031)
12.7 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.1.3 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 AtriCure
13.2.1 AtriCure Company Information
13.2.2 AtriCure Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.2.3 AtriCure Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AtriCure Main Business Overview
13.2.5 AtriCure Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 Johnson and Johnson
13.4.1 Johnson and Johnson Company Information
13.4.2 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.4.3 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson and Johnson Main Business Overview
13.4.5 Johnson and Johnson Latest Developments
13.5 Lifetech Scientific Corporation
13.5.1 Lifetech Scientific Corporation Company Information
13.5.2 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.5.3 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lifetech Scientific Corporation Main Business Overview
13.5.5 Lifetech Scientific Corporation Latest Developments
13.6 Occlutech GmbH
13.6.1 Occlutech GmbH Company Information
13.6.2 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.6.3 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Occlutech GmbH Main Business Overview
13.6.5 Occlutech GmbH Latest Developments
13.7 Biosense Webster Inc
13.7.1 Biosense Webster Inc Company Information
13.7.2 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.7.3 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Biosense Webster Inc Main Business Overview
13.7.5 Biosense Webster Inc Latest Developments
13.8 SentreHeart Inc.
13.8.1 SentreHeart Inc. Company Information
13.8.2 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.8.3 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 SentreHeart Inc. Main Business Overview
13.8.5 SentreHeart Inc. Latest Developments
13.9 MEDX Xelerator LP
13.9.1 MEDX Xelerator LP Company Information
13.9.2 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.9.3 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 MEDX Xelerator LP Main Business Overview
13.9.5 MEDX Xelerator LP Latest Developments
13.10 Cardia Inc
13.10.1 Cardia Inc Company Information
13.10.2 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
13.10.3 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cardia Inc Main Business Overview
13.10.5 Cardia Inc Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.